ADC Excellence Awards

The Asia-Pacific Biopharma Excellence Awards (ABEA) 2025 proudly celebrates the outstanding achievements and innovations that are driving the biopharma industry forward across Asia.

Key Dates:
Voting Opens: 2nd December 2024
Voting Closes: 2nd February 2025
Award Ceremony: 12th March 2025

We invite you to participate by casting your vote and celebrating the exceptional contributions of individuals and companies making a difference in the biopharma sector.
1.Best ADC Platform Technology
2.Best ADC Developer in China
3.Best ADC Developer in Taiwan
4.Best ADC Developer in South Korea
5.Best ADC Developer in Japan
6.Best ADC Developer in South East Asia
7.Most Promising ADC Clinical Candidate in China
8.Most Promising ADC Clinical Candidate in Taiwan
9.Most Promising ADC Clinical Candidate in South Korea
10.Most Promising ADC Clinical Candidate in Japan
11.Most Promising ADC Clinical Candidate in Asia
12.Best ADC CDMO in China
13.Best ADC CDMO in Taiwan
14.Best ADC CDMO in South Korea
15.Best ADC CDMO in Asia
16.Best ADC CRO in Asia
Thank you for voting. For more information on the awards, categories, and shortlisted nominees, visit the official ABEA 2025 website.